propranolol has been researched along with Cardiovascular Pregnancy Complications in 72 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We compared propranolol with methyldopa in a randomized prospective study of 28 women with pregnancy associated hypertension." | 9.05 | Propranolol in pregnancy three year prospective study. ( Bevan, EB; Craswell, PW; Eadie, MJ; Livingstone, I; Smith, MT, 1983) |
| "The treatment of the mentioned forms of hypertension with propranolol during pregnancy either as monotherapy or in combination with dihydralazine and after careful exclusion of the contraindications described represents a further effective therapy." | 7.67 | [Experiences with propranolol (Obsidan25) in hypertension therapy in pregnancy]. ( Glöckner, R; Peiker, G; Siegert, C; Traeger, A; Völkner, E, 1985) |
| "A hypertensive women was treated throughout pregnancy with propranolol 40 mg daily without complication." | 7.66 | Anti-hypertensive therapy with propranolol during pregnancy and lactation. ( Taylor, EA; Turner, P, 1981) |
| "A combination of propranolol and hydrallazine was administered to 13 patients with longstanding hypertension during 15 pregnancies." | 7.66 | Propranolol and hydrallazine in the management of essential hypertension in pregnancy. ( Bott-Kanner, G; Joel-Cohen, SJ; Reisner, SH; Rosenfeld, JB; Schweitzer, A, 1980) |
| "A case is presented of a low birth weight infant born prematurely with depressed respiration, sinus bradycardia, and hypoglycemia associated with maternal propranolol therapy during pregnancy and up until labor and delivery." | 7.66 | Propranolol therapy during pregnancy in a patient with idiopathic hypertrophic subaortic stenosis: is it safe? ( Curry, RC; Sabom, MB; Wise, DE, 1978) |
| "Twenty-five women were treated with propranolol during 26 pregnancies complicated by hypertension." | 7.66 | Propranolol for the treatment of hypertension in pregnancy. ( Eliahou, HE; Mashiach, S; Reisin, E; Romem, I; Serr, DM; Silverberg, DS, 1978) |
| "A retrospective study is presented of the effect of propranolol on fetal outcome in pregnancies complicated by maternal hypertension." | 7.66 | The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension. ( Beard, RW; Belsey, E; Cohen, SL; Lieberman, BA; Pinker, GD; Stirrat, GM, 1978) |
| "Ten hypertensive patients were treated with propranolol throughout pregnancy." | 7.65 | [Treatment of arterial hypertension with propranolol in pregnant women. 10 cases]. ( Kreft, C; Tcherdakoff, Ph, 1977) |
| "The administration of 160 mg of propranolol during pregnancy, labor, and delivery was associated with profound hypoglycemia and respiratory depression in a newborn infant." | 7.65 | Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition. ( Cottrill, CM; Gettes, L; McAllister, RG; Noonan, JA, 1977) |
| "Treatment with propranolol and hydralazine was effective in controlling her blood pressure and was continued throughout her next two pregnancies, both of which were successful." | 5.26 | Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report. ( Bott-Kanner, G; Joel-Cohen, J; Rosenfeld, JB; Schoenfeld, A; Schweitzer, A, 1978) |
| "Fifty-one women with pregnancy-induced hypertension (PIH) were randomly allocated to one of three treatment groups: A: hydralazine (13); B: hydralazine and propranolol (17); and C: hydralazine and pindolol (19)." | 5.08 | Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension. ( Holzberg, G; Insler, V; Mazor, M; Paran, E; Zmora, E, 1995) |
| "We compared propranolol with methyldopa in a randomized prospective study of 28 women with pregnancy associated hypertension." | 5.05 | Propranolol in pregnancy three year prospective study. ( Bevan, EB; Craswell, PW; Eadie, MJ; Livingstone, I; Smith, MT, 1983) |
| "The treatment of the mentioned forms of hypertension with propranolol during pregnancy either as monotherapy or in combination with dihydralazine and after careful exclusion of the contraindications described represents a further effective therapy." | 3.67 | [Experiences with propranolol (Obsidan25) in hypertension therapy in pregnancy]. ( Glöckner, R; Peiker, G; Siegert, C; Traeger, A; Völkner, E, 1985) |
| "A hypertensive women was treated throughout pregnancy with propranolol 40 mg daily without complication." | 3.66 | Anti-hypertensive therapy with propranolol during pregnancy and lactation. ( Taylor, EA; Turner, P, 1981) |
| "A combination of propranolol and hydrallazine was administered to 13 patients with longstanding hypertension during 15 pregnancies." | 3.66 | Propranolol and hydrallazine in the management of essential hypertension in pregnancy. ( Bott-Kanner, G; Joel-Cohen, SJ; Reisner, SH; Rosenfeld, JB; Schweitzer, A, 1980) |
| "A case is presented of a low birth weight infant born prematurely with depressed respiration, sinus bradycardia, and hypoglycemia associated with maternal propranolol therapy during pregnancy and up until labor and delivery." | 3.66 | Propranolol therapy during pregnancy in a patient with idiopathic hypertrophic subaortic stenosis: is it safe? ( Curry, RC; Sabom, MB; Wise, DE, 1978) |
| "Twenty-five women were treated with propranolol during 26 pregnancies complicated by hypertension." | 3.66 | Propranolol for the treatment of hypertension in pregnancy. ( Eliahou, HE; Mashiach, S; Reisin, E; Romem, I; Serr, DM; Silverberg, DS, 1978) |
| "A retrospective study is presented of the effect of propranolol on fetal outcome in pregnancies complicated by maternal hypertension." | 3.66 | The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension. ( Beard, RW; Belsey, E; Cohen, SL; Lieberman, BA; Pinker, GD; Stirrat, GM, 1978) |
| "Ten hypertensive patients were treated with propranolol throughout pregnancy." | 3.65 | [Treatment of arterial hypertension with propranolol in pregnant women. 10 cases]. ( Kreft, C; Tcherdakoff, Ph, 1977) |
| "The administration of 160 mg of propranolol during pregnancy, labor, and delivery was associated with profound hypoglycemia and respiratory depression in a newborn infant." | 3.65 | Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition. ( Cottrill, CM; Gettes, L; McAllister, RG; Noonan, JA, 1977) |
| "Pregnancy in the Marfan syndrome is associated with two primary problems: potential catastrophic aortic dissection and the risk for having a child with the syndrome." | 2.39 | Cardiovascular problems in pregnant women with the Marfan syndrome. ( Elkayam, U; Mehra, A; Ostrzega, E; Shotan, A, 1995) |
| "During evaluation for palpitations, presyncope, or syncope, seven pregnant women had documented ventricular tachycardia." | 2.38 | New-onset ventricular tachycardia during pregnancy. ( Allen, B; Brodsky, M; Doria, R; Sada, M; Sato, D; Thomas, G, 1992) |
| "The use of beta blockers during treatment of mitral stenosis is discussed on four cases involving females patients who are symptomatic." | 1.30 | [Role of beta-blockers in the treatment of mitral stenosis, apropos of 4 cases]. ( Ba, SA; Diop, IB; Diouf, SM; Fall, MD; Hane, L; Kane, A; Sarr, M, 1997) |
| "Supraventricular tachycardia is relatively common in pregnancy, and is related to the normal physiologic changes of the cardiovascular system in the gravid state." | 1.28 | Supraventricular tachycardia resistant to treatment in a pregnant woman. ( Hulkower, S; Kostic, B; Treakle, K, 1992) |
| "Renal hypertension was induced by clamping both renal arteries 4 weeks before pregnancy." | 1.27 | The acute effects of a non-selective beta-adrenergic blocking agent in hypertensive pregnant rats. ( Karlsson, K; Ljungblad, U; Lundgren, Y, 1984) |
| "Propranolol is a beta-adrenergic blocking drug with a wide spectrum of use and may diverse pharmacologic effects." | 1.26 | Propranolol and parturition. ( Datta, S; Kitzmiller, JL; Ostheimer, GW; Schoenbaum, SC, 1978) |
| "Treatment with propranolol and hydralazine was effective in controlling her blood pressure and was continued throughout her next two pregnancies, both of which were successful." | 1.26 | Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report. ( Bott-Kanner, G; Joel-Cohen, J; Rosenfeld, JB; Schoenfeld, A; Schweitzer, A, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 61 (84.72) | 18.7374 |
| 1990's | 8 (11.11) | 18.2507 |
| 2000's | 1 (1.39) | 29.6817 |
| 2010's | 2 (2.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Lee, MS | 1 |
| Habashi, JP | 1 |
| MacFarlane, EG | 1 |
| Bagirzadeh, R | 1 |
| Bowen, C | 1 |
| Huso, N | 1 |
| Chen, Y | 1 |
| Bedja, D | 1 |
| Creamer, TJ | 1 |
| Rykiel, G | 1 |
| Manning, M | 1 |
| Huso, D | 1 |
| Dietz, HC | 1 |
| Tang, RA | 1 |
| Dorotheo, EU | 1 |
| Schiffman, JS | 1 |
| Bahrani, HM | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Karlsson, K | 1 |
| Lundgren, Y | 1 |
| Ljungblad, U | 1 |
| Halawa, B | 1 |
| Mazurek, W | 1 |
| Margulis, E | 1 |
| Binder, D | 1 |
| Cohen, AW | 1 |
| Bruner, JP | 1 |
| Barry, MJ | 1 |
| Elliott, JP | 1 |
| Livingstone, I | 1 |
| Craswell, PW | 1 |
| Bevan, EB | 1 |
| Smith, MT | 1 |
| Eadie, MJ | 1 |
| Berkowitz, RL | 1 |
| Ueland, K | 1 |
| McAnulty, JH | 1 |
| Ueland, FR | 1 |
| Metcalfe, J | 1 |
| Alpert, BS | 1 |
| Boineau, J | 1 |
| Strong, WB | 1 |
| Boice, JL | 1 |
| Silas, JH | 1 |
| Woods, HF | 1 |
| Singer, A | 1 |
| Brown, VA | 1 |
| Taylor, EA | 1 |
| Turner, P | 1 |
| Bott-Kanner, G | 2 |
| Schweitzer, A | 2 |
| Reisner, SH | 1 |
| Joel-Cohen, SJ | 1 |
| Rosenfeld, JB | 2 |
| Paran, E | 1 |
| Holzberg, G | 1 |
| Mazor, M | 1 |
| Zmora, E | 1 |
| Insler, V | 1 |
| Elkayam, U | 1 |
| Ostrzega, E | 1 |
| Shotan, A | 1 |
| Mehra, A | 1 |
| Cheng, TO | 1 |
| Kam, RM | 1 |
| Lee, CY | 1 |
| Teo, WS | 1 |
| McCurdy, CM | 1 |
| Rutherford, SE | 1 |
| Coddington, CC | 1 |
| Kane, A | 1 |
| Ba, SA | 1 |
| Fall, MD | 1 |
| Sarr, M | 1 |
| Diop, IB | 1 |
| Hane, L | 1 |
| Diouf, SM | 1 |
| Tcherdakoff, P | 3 |
| Dubois, D | 1 |
| Petitcolas, J | 1 |
| Monnier, JC | 1 |
| Honore, P | 1 |
| Lanciaux, B | 1 |
| Boulogne, M | 1 |
| Greer, M | 1 |
| Serup, J | 2 |
| Sachs, BP | 1 |
| Van Iddekinge, B | 1 |
| Tcherdakoff, Ph | 2 |
| Kreft, C | 3 |
| Sabom, MB | 1 |
| Curry, RC | 1 |
| Wise, DE | 1 |
| Datta, S | 1 |
| Kitzmiller, JL | 1 |
| Ostheimer, GW | 2 |
| Schoenbaum, SC | 1 |
| Oakley, GD | 1 |
| McGarry, K | 1 |
| Limb, DG | 1 |
| Oakley, CM | 3 |
| Pruyn, SC | 1 |
| Phelan, JP | 1 |
| Buchanan, GC | 1 |
| Eliahou, HE | 1 |
| Silverberg, DS | 1 |
| Reisin, E | 1 |
| Romem, I | 1 |
| Mashiach, S | 1 |
| Serr, DM | 1 |
| Schoenfeld, A | 1 |
| Joel-Cohen, J | 1 |
| Lieberman, BA | 1 |
| Stirrat, GM | 1 |
| Cohen, SL | 1 |
| Beard, RW | 1 |
| Pinker, GD | 1 |
| Belsey, E | 1 |
| Colliard, M | 1 |
| Berrard, E | 1 |
| Dupay, A | 1 |
| Bernaille, JM | 1 |
| Cottrill, CM | 1 |
| McAllister, RG | 1 |
| Gettes, L | 1 |
| Noonan, JA | 1 |
| Alper, MH | 1 |
| Kolibash, AJ | 1 |
| Ruiz, DE | 1 |
| Lewis, RP | 1 |
| Woods, JR | 1 |
| Brinkman, CR | 1 |
| Tymieniecka-Iwanik, J | 1 |
| Wszelaki-Lass, E | 1 |
| Treakle, K | 1 |
| Kostic, B | 1 |
| Hulkower, S | 1 |
| Brodsky, M | 1 |
| Doria, R | 1 |
| Allen, B | 1 |
| Sato, D | 1 |
| Thomas, G | 1 |
| Sada, M | 1 |
| Fogari, R | 1 |
| Zoppi, A | 1 |
| Kawecka-Jaszcz, K | 1 |
| Skoczeń, M | 1 |
| Norès, JM | 1 |
| Lignières, G | 1 |
| Hoffmann-Traeger, A | 1 |
| Peiker, G | 2 |
| Glöckner, R | 2 |
| Wittmann, I | 1 |
| Balogh, A | 1 |
| Henschel, L | 1 |
| Rubin, PC | 1 |
| Butters, L | 1 |
| McCabe, R | 1 |
| Kelman, A | 1 |
| Cola, LM | 1 |
| Lavin, JP | 1 |
| Bergmans, MG | 1 |
| Jonker, GJ | 1 |
| Kock, HC | 1 |
| Schalm, SW | 1 |
| van Buuren, HR | 1 |
| Redgrave, JE | 1 |
| Swartz, SL | 1 |
| Campbell, JW | 1 |
| Siegert, C | 1 |
| Völkner, E | 1 |
| Traeger, A | 1 |
| Requena Laviña, M | 1 |
| Cosío, FG | 1 |
| Fernández-Yáñez, J | 1 |
| García Alarilla, M | 1 |
| Bajo Arenas, J | 1 |
| Fiddler, GI | 1 |
| Goodwin, JF | 2 |
| Perrotin, M | 1 |
| Pauly-Laubry, C | 1 |
| Forman, J | 1 |
| Maurice, P | 1 |
| Turner, GM | 1 |
| Dixon, HG | 1 |
| Fernandes, M | 1 |
| Kim, KE | 1 |
| Moyer, JH | 1 |
| Levitan, AA | 1 |
| Manion, JC | 1 |
| Maljar, L | 1 |
| Sakson, N | 1 |
| Szwarc, B | 1 |
| Morín, T | 1 |
| Aitken, RR | 1 |
| Drake, CG | 1 |
| Batts, JA | 1 |
| Tchilinguirian, NG | 1 |
| Passmore, J | 1 |
| Schroeder, JS | 1 |
| Harrison, DC | 1 |
| Ledwich, JR | 1 |
| Fay, JE | 1 |
| Seaton, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients: a Double-blind Randomized Controlled Trial[NCT03348683] | Phase 2 | 240 participants (Actual) | Interventional | 2017-12-11 | Completed | ||
| Propranolol for Prolonged Labor: A Randomized Controlled Trial (PRO-Labor Trial)[NCT04741698] | Phase 1 | 80 participants (Actual) | Interventional | 2021-07-27 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Time of latent labor defined as <6cm of cervical dilation. (NCT03348683)
Timeframe: average of 24 hours
| Intervention | hours (Mean) |
|---|---|
| Propranolol | 11.0 |
| Placebo | 11.2 |
Count of fetus with fetal bradycardia (<110bpm for >10 minutes within 30 minutes of study drug administration) (NCT03348683)
Timeframe: 30 minutes from drug administration
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 1 |
| Placebo | 0 |
Count of fetus with fetal heart rate decelerations within 30 minutes of study drug administration (NCT03348683)
Timeframe: 30 minutes from drug administration
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 15 |
| Placebo | 13 |
"Neonatal outcome - Number of neonates with hypoglycemia (blood glucose <50).~This population includes only the neonates who had heelsticks to check their blood glucose, which is not a universal practice and was not required by the protocol or IRB. The neonates included were those who met the nursery's risk-based protocol to check blood glucose after birth (ex: infants of diabetic mothers, fetal growth restriction, macrosomia, or symptoms suggestive of hypoglycemia)" (NCT03348683)
Timeframe: Day 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 11 |
| Placebo | 8 |
"Composite neonatal outcome score was for any of the following morbidity: Neonatal Intensive Care Unit (NICU) admission, respiratory support (CPAP, nasal cannula, intubation), culture proven sepsis, radiographically proven intracranial hemorrhage, necrotizing enterocolitis, hypoglycemia (for those infants who had sugar checked), and neonatal death.~The composite score was computed as a score of 1 for any indication of neonatal morbidity - neonates who experienced at least one morbidity and the components are given equal weights. Patients who had no evidence of the predefined neonatal morbidities are subsequently given a score of 0. The minimum is 0 and maximum is 1." (NCT03348683)
Timeframe: Day 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 21 |
| Placebo | 28 |
"Composite maternal morbidity score consists of a count of postpartum hemorrhage, transfusion, hysterectomy, placental abruption, chorioamnionitis, shoulder dystocia, episiotomy, higher order laceration, and ICU admission.~The composite score was computed as a score of 1 for any indication of maternal morbidity, that is the participant experienced at least one maternal morbidity, and the components are given equal weights. Participants who had no evidence of the predefined maternal morbidities are subsequently given a score of 0. The minimum is 0 and maximum is 1." (NCT03348683)
Timeframe: average of 24 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 35 |
| Placebo | 49 |
Greater than 500cc of blood expelled during a vaginal delivery or greater than 1000cc of blood expelled during a cesarean section (NCT03348683)
Timeframe: 30 minutes from drug administration
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 15 |
| Placebo | 26 |
The time of induction (based on time of foley balloon placement for cervical ripening or misoprostol administration) to the time of delivery of the infant. (NCT03348683)
Timeframe: average of 24 hours
| Intervention | hours (Mean) |
|---|---|
| Propranolol | 13.8 |
| Placebo | 14.3 |
Number of various mode of delivery - count of Vaginal delivery, vacuum assisted vaginal delivery, forceps assisted vaginal delivery, cesarean section (NCT03348683)
Timeframe: average of 24 hours
| Intervention | Participants (Count of Participants) | |||
|---|---|---|---|---|
| Spontaneous vaginal delivery | Vacuum assisted vaginal delivery | Forceps assisted vaginal delivery | Cesarean section | |
| Placebo | 61 | 10 | 8 | 40 |
| Propranolol | 64 | 3 | 8 | 46 |
12 reviews available for propranolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
[Cardiomyopathies and their treatment].
Topics: Adult; Aged; Aortic Stenosis, Subvalvular; Cardiomegaly; Cardiomyopathies; Cardiomyopathy, Alcoholic | 1980 |
Anti-hypertensive drugs in the pregnant patient.
Topics: Antihypertensive Agents; Chronic Disease; Clonidine; Diazoxide; Diuretics; Female; Fetus; Furosemide | 1980 |
Special considerations in the use of cardiovascular drugs.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Cardiac Glycosides; Cardiovascular Agents; Disopyramide; Diu | 1981 |
Cardiovascular problems in pregnant women with the Marfan syndrome.
Topics: Delivery, Obstetric; Female; Genetic Counseling; Humans; Labor, Obstetric; Marfan Syndrome; Pregnanc | 1995 |
[Propranolol in treatment of hypertension in pregnancy].
Topics: Female; Hemodynamics; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Complications; Pre | 1979 |
New-onset ventricular tachycardia during pregnancy.
Topics: Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Exercise Test; Female; Follo | 1992 |
[Beta-blockers in the therapy of arterial hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Diuretics; Female; Humans; Hypertension; Methyldopa; Oxprenolol; Pre-Ec | 1985 |
[Beta-blockaders in the treatment of hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Evaluation; Female; Humans; Hypertension; Metoprolol; Ox | 1985 |
Fetal supraventricular tachycardia. Review of the literature.
Topics: Adult; Cesarean Section; Digitalis; Drug Therapy, Combination; Electric Countershock; Electrocardiog | 1985 |
The cardiomyopathies.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticoagulants; Atrial Fibrillation; Cardiomegaly; Car | 1972 |
Hypertensive emergencies.
Topics: Acute Kidney Injury; Adrenal Gland Neoplasms; Antihypertensive Agents; Aortic Aneurysm; Blood Volume | 1974 |
3 trials available for propranolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Propranolol in pregnancy three year prospective study.
Topics: Blood Pressure; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Kinetics; Lactates; | 1983 |
Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; Drug Therapy, Combination; Female | 1995 |
Prevention of recurrent variceal bleeding: non-surgical procedures.
Topics: Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Humans; Liver Circulation; Liver C | 1985 |
57 other studies available for propranolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
Oxytocin antagonism prevents pregnancy-associated aortic dissection in a mouse model of Marfan syndrome.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Aortic Dissection; Disease Models, Animal; Female; Hydr | 2019 |
Medical and surgical management of idiopathic intracranial hypertension in pregnancy.
Topics: Adolescent; Adult; Anticonvulsants; Antihypertensive Agents; Diagnosis, Differential; Diuretics; Fem | 2004 |
Beta-blockers in pregnancy.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Female; Fetus; Humans; Hypertension; In | 1982 |
The acute effects of a non-selective beta-adrenergic blocking agent in hypertensive pregnant rats.
Topics: Adrenergic beta-Antagonists; Animals; Cardiac Output; Female; Heart Rate; Hemodynamics; Hypertension | 1984 |
The effect of propranolol on the nonstress test.
Topics: Adolescent; Adult; Female; Fetal Monitoring; Fetus; Humans; Hypertension; Pregnancy; Pregnancy Compl | 1984 |
Pregnancy in a patient with idiopathic long QT syndrome.
Topics: Adult; Arrhythmias, Cardiac; Autonomic Nerve Block; Electrocardiography; Female; Heart; Humans; Preg | 1984 |
Exercise-induced ventricular tachycardia.
Topics: Adolescent; Child; Electrocardiography; Exercise Test; Female; Heart Rate; Heart Ventricles; Humans; | 1982 |
Propranolol during pregnancy.
Topics: Female; Fetus; Humans; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Cardiovascular; | 1982 |
Successful pregnancy soon after oral contraceptive-associated malignant hypertension.
Topics: Adult; Contraceptives, Oral; Female; Humans; Hypertension, Malignant; Pregnancy; Pregnancy Complicat | 1980 |
Anti-hypertensive therapy with propranolol during pregnancy and lactation.
Topics: Breast Feeding; Female; Humans; Hypertension; Infant, Newborn; Lactation; Milk, Human; Pregnancy; Pr | 1981 |
Propranolol and hydrallazine in the management of essential hypertension in pregnancy.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Hypoglycemia; Infant, N | 1980 |
Caution in use of beta blockers during pregnancy.
Topics: Adrenergic beta-Antagonists; Catheterization; Female; Heart Rate; Humans; Infant, Newborn; Maternal- | 1995 |
A pregnant lady with narrow complex tachycardia.
Topics: Adult; Diagnosis, Differential; Digoxin; Drug Therapy, Combination; Electrocardiography; Female; Hum | 1994 |
Syncope and sudden arrhythmic death complicating pregnancy. A case report of Romano-Ward syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Bradycardia; Cesarean Section; Death, Sudden, Cardiac; Electric | 1993 |
[Role of beta-blockers in the treatment of mitral stenosis, apropos of 4 cases].
Topics: Adrenergic beta-Antagonists; Adult; Anemia; Anti-Arrhythmia Agents; Digitalis Glycosides; Diuretics; | 1997 |
[Beta-blockers and arterial hypertension in the pregnant woman].
Topics: Adrenergic beta-Antagonists; Female; Fetal Heart; Humans; Hypertension; Maternal-Fetal Exchange; Pre | 1978 |
[beta-blockers and high risk pregnancies. Viewpoint of the nephrologist and the obstetrician].
Topics: Acebutolol; Adrenergic beta-Antagonists; Female; Humans; Hypertension; Pindolol; Pregnancy; Pregnanc | 1978 |
[Value of hydralazine-beta blockader association in hypertension of pregnancy].
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Fetus; Humans; Hydralazine; H | 1978 |
Pre-term baby: an inheritance of a different kind.
Topics: Adult; Female; Humans; Hypertension; Infant, Newborn; Infant, Premature, Diseases; Male; Pregnancy; | 1979 |
Successful pregnancy in a patient with autosomal dominant ventricular dysrhythmia.
Topics: Adult; Arrhythmias, Cardiac; Chromosome Aberrations; Chromosome Disorders; Female; Fetal Death; Gene | 1979 |
Propranolol for the treatment of hypertension in pregnancy.
Topics: Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol | 1979 |
[Treatment of arterial hypertension with propranolol in pregnant women. 10 cases].
Topics: Adult; Birth Weight; Blood Pressure; Cesarean Section; Delivery, Obstetric; Female; Humans; Hyperten | 1977 |
Propranolol therapy during pregnancy in a patient with idiopathic hypertrophic subaortic stenosis: is it safe?
Topics: Adult; Aortic Stenosis, Subvalvular; Cardiomyopathy, Hypertrophic; Female; Fetus; Heart Rate; Humans | 1978 |
Propranolol and parturition.
Topics: Adult; Anesthesia, Local; Anesthesia, Obstetrical; Aortic Stenosis, Subvalvular; Cardiomyopathy, Hyp | 1978 |
Management of pregnancy in patients with hypertrophic cardiomyopathy.
Topics: Adult; Cardiomyopathy, Hypertrophic; Delivery, Obstetric; Depression, Chemical; Female; Fetal Heart; | 1979 |
Long-term propranolol therapy in pregnancy: maternal and fetal outcome.
Topics: Asphyxia Neonatorum; Bradycardia; Female; Fetal Growth Retardation; Fetus; Humans; Hypertension; Hyp | 1979 |
Long-term propranolol therapy in pregnancy: maternal and fetal outcome.
Topics: Asphyxia Neonatorum; Bradycardia; Female; Fetal Growth Retardation; Fetus; Humans; Hypertension; Hyp | 1979 |
Long-term propranolol therapy in pregnancy: maternal and fetal outcome.
Topics: Asphyxia Neonatorum; Bradycardia; Female; Fetal Growth Retardation; Fetus; Humans; Hypertension; Hyp | 1979 |
Long-term propranolol therapy in pregnancy: maternal and fetal outcome.
Topics: Asphyxia Neonatorum; Bradycardia; Female; Fetal Growth Retardation; Fetus; Humans; Hypertension; Hyp | 1979 |
Propranolol for the treatment of hypertension in pregnancy.
Topics: Adult; Apgar Score; Chlorthalidone; Female; Fetal Death; Humans; Hypertension; Infant, Newborn; Infa | 1978 |
Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Pregnancy; Pregnancy Co | 1978 |
The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension.
Topics: Birth Weight; Female; Fetal Death; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Compl | 1978 |
Propranolol in hypertension during pregnancy.
Topics: Adult; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol | 1978 |
Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition.
Topics: Adult; Apnea; Female; Humans; Hypoglycemia; Infant, Newborn; Infant, Newborn, Diseases; Male; Matern | 1977 |
[Use of beta blockers (propranolol) in the treatment of arterial hypertension during pregnancy].
Topics: Drug Evaluation; Female; Fetus; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Complica | 1977 |
Intrapartum anesthetic management of the pregnant patient with heart disease.
Topics: Anesthesia, Epidural; Anesthesia, General; Anesthesia, Inhalation; Anesthesia, Local; Anesthesia, Ob | 1975 |
Idiopathic hypertrophic subaortic stenosis in pregnancy.
Topics: Adult; Aortic Stenosis, Subvalvular; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Cineangi | 1975 |
The treatment of gestational hypertension.
Topics: Antihypertensive Agents; Chronic Disease; Diazoxide; Female; Humans; Hydralazine; Hypertension; Hype | 1975 |
[Evaluation of the action of Polfa propranolol administered to women with various pathological conditions].
Topics: Female; Humans; Hyperthyroidism; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardio | 1976 |
Supraventricular tachycardia resistant to treatment in a pregnant woman.
Topics: Adult; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electric Countershock; Female; Flecainide; | 1992 |
[Hypertension in pregnant women and beta-blockers. Follow-up of 31 pregnancies].
Topics: Adult; Blood Pressure; Embryonic and Fetal Development; Female; Follow-Up Studies; Humans; Hypertens | 1988 |
The influence of phenobarbital on the pharmacokinetics of propranolol in pregnancy.
Topics: Drug Interactions; Female; Half-Life; Humans; Hypertension; Phenobarbital; Pregnancy; Pregnancy Comp | 1987 |
The influence of pregnancy on drug action: concentration-effect modelling with propranolol.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Kinetics; Pregnancy; Pregnancy Comp | 1987 |
Pregnancy complicated by Marfan's syndrome with aortic arch dissection, subsequent aortic arch replacement and triple coronary artery bypass grafts.
Topics: Adult; Aorta, Thoracic; Aortic Aneurysm; Aortic Dissection; Cesarean Section; Coronary Artery Bypass | 1985 |
Diagnosis and management of malignant hypertension.
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Malignant; Kidney Function Tests | 1985 |
A possible teratogenic effect of propranolol.
Topics: Abnormalities, Drug-Induced; Adult; Female; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregna | 1985 |
[Experiences with propranolol (Obsidan25) in hypertension therapy in pregnancy].
Topics: Blood Pressure; Dihydralazine; Female; Heart Rate; Humans; Hypertension; Infant, Newborn; Kinetics; | 1985 |
[Treatment of mitral stenosis with propranolol in pregnancy and the puerperium].
Topics: Adult; Diuretics; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Mitral Valve Stenosis; | 1985 |
Letter: Propranolol and pregnancy.
Topics: Adult; Birth Weight; Cardiomegaly; Female; Fetus; Humans; Hypoglycemia; Infant, Newborn; Infant, New | 1974 |
Congestive and hypertrophic cardiomyopathies. A decade of study.
Topics: Blood Pressure; Cardiomegaly; Coronary Disease; Death, Sudden; Dilatation; Female; Heart Diseases; H | 1970 |
[Obstructive cardiomyopathy and atrio-ventricular conduction disorder].
Topics: Adult; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Electrocardiography; Electrodes, Impla | 1973 |
Management of pregnancy complicated by hypertrophic obstructive cardiomyopathy.
Topics: Adolescent; Adult; Blood Transfusion; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cesarean Section; | 1968 |
Propranolol therapy during pregnancy and lactation.
Topics: Female; Humans; Lactation; Milk, Human; Pregnancy; Pregnancy Complications, Cardiovascular; Proprano | 1973 |
[Thyrotoxic cardiopathy in pregnancy].
Topics: Administration, Oral; Adult; Female; Humans; Hyperthyroidism; Injections, Intravenous; Potassium Iod | 1973 |
A technique of anesthesia with induced hypotension for surgical correction of intracranial aneurysms.
Topics: Anesthesia, General; Blood Pressure Determination; Female; Halothane; Humans; Hypotension, Controlle | 1974 |
Pheochromocytoma in pregnancy: a case report and review of the pathophysiology.
Topics: Adrenal Gland Neoplasms; Adult; Catecholamines; Cesarean Section; Epinephrine; Female; Heart Arrest; | 1974 |
Repeated cardioversion during pregnancy. Treatment of refractory paroxysmal atrial tachycardia during 3 successive pregnancies.
Topics: Adult; Electric Countershock; Electrocardiography; Female; Humans; Pregnancy; Pregnancy Complication | 1971 |
Idiopathic recurrent ventricular fibrillation.
Topics: Adult; Electrocardiography; Female; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complicati | 1969 |
Quinidine-induced paroxysmal ventricular fibrillation treated with propranolol.
Topics: Adult; Atrial Fibrillation; Female; Humans; Mitral Valve Stenosis; Pregnancy; Pregnancy Complication | 1966 |